Researchers Edited Mouse Genes To Force Their Liver To Produce Its Own GLP-1 Drugs… And It Worked For 28 Weeks
Shutterstock Modern medicine can do some amazing things, and has saved the lives of countless millions of people. There are, however, some drawbacks to most medications. For one, it can be very expensive. Another issue is that some of them are difficult to develop, resulting in occasional shortages. Finally, the medication is generic in the […]
Texas Is Suing Tylenol Makers Over Claims of Links to Autism. Here’s Everything to Know About the Lawsuit
Texas Attorney General Ken Paxton is suing the pharmaceutical companies behind Tylenol for “deceptively marketing” the medication as a safe option for pregnant mothers. The lawsuit against Johnson & Johnson and Kenvue, which Paxton filed on Tuesday, claimed that the companies knew that being exposed to acetaminophen, the active ingredient in Tylenol, before birth or […]
More than a third of Lilly’s new Zepbound prescriptions are coming from DTC
The impact of pharma’s direct-to-patient efforts is getting clearer. When Lilly launched its LillyDirect program in January 2024, it wasn’t immediately clear how big the business would be. And for a while …
Weight Loss Drugs May Also Curb Substance Use Disorders
Research has suggested the potential of GLP-1 medications for treating substance use disorders, including alcohol, opioids, nicotine, and psychostimulants.
STAT+: Pharmalittle: We’re reading about rising GLP-1 use, a psychedelic therapy for depression, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a good start here on the Pharmalot campus, where we have cool breezes and clear blue skies greeting us today. Who could ask for anything more? Actually, we could — it is time to reheat the coffee kettle for […]
How Skin-Care Brand Fitish is Making Prescription GLP-1 Meds Part of Its Business Model
Despite the growing ubiquity of GLP-1 (glucagon-like peptide-1) medication use, there is still quite a bit of confusion, stigma and misinformation surrounding injections like Ozempic. There’s also a major lack of access for many patients who stand to benefit from the meds; Fitish founder Jenna … Continue reading
The Needle and the Nation: How Ozempic, Wegovy, Mounjaro, and other GLP-1 drugs are quietly deflating America’s wasteline
According to the Gallup National Health and Well-Being Index, America’s adult obesity rate has fallen to 37% in 2025, down from 39.9% in 2022 — a small but significant drop after decades of stagnation. Over the same period, the number of people taking injectable anti-obesity drugs more than doubled, from 5.8% to 12.4%. Coincidence? Perhaps. […]
Glucagon-Like Peptide-1 Analogues Market to Surpass USD 299.08 Billion by 2033, Fueled by the Weight Management and Diabetes Revolution | DataM Intelligence
AUSTIN, Texas and TOKYO, Oct. 28, 2025 /PRNewswire/ — According to DataM Intelligence, the Glucagon-like Peptide-1 (GLP-1) Analogues Market is witnessing a transformative expansion, driven by soaring demand for effective obesity management and type 2 diabetes therapies. The GLP-1…
Found Health Launches GLP-1 Microdosing Program for Early Metabolic Dysfunction
MIAMI–(BUSINESS WIRE)–Found, the doctor-designed telehealth platform specializing in personalized weight care since 2019, today announced the launch of its GLP-1 Microdosing Program. The program addresses a critical gap in preventive care: patients with early metabolic dysfunction often wait years for treatment until their condition worsens to meet traditional prescribing thresholds. “For too long, healthcare has […]
Obesity Rate Declining in U.S.
The U.S. obesity rate is showing signs of abating from its 2022 high. GLP-1 antidiabetic injectables used for weight loss may be playing a role.